Applications Published 21 March 2001
Published: 20-Dec-2001
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Bacteriophage transgenic fish for mutation detection
The University of Georgia Research Foundation 1083788*Liquid aqueous compsn with improved stability
Colgate-Palmolive 1083878*Methods and devices for providing prolonged drug therapy
Alza Corp 1083879*Stable gel mixture in the form of a mixture of oleogel and aqueous gel
Alache, Jean-Marc 1083880*Liposome compsn and method for administering a quinolone
Alza Corp 1083881*A hepatocyte targeting polyethylene glyco-crafted poly-L-lysine polymeric gene carrier
Expression Genetics 1082882*Stabilisers for lyophilised vaccines
Merck 1083883*Stabilised polyvinylpyrrolidone formulation
BASF 1083884*Delavirdine tablet formulation
Pharmacia & Upjohn 1083885*Drug delivery system comprising a tightly compacted solid medicament stock
Euroceltique 1083886*Pharmaceutical compsns for ulcer
Nicox 1083887*Multibinding agents that modulate PPARgamma and RXR receptors
Advanced Medicine 1083888*Method for trating neurodegenrative disorders
Ortho-McNeil Pharmaceutical 1083889*N-acetyl 3-chloroprocainamide, acid addition salts thereof, and methods of use
Oxigene 1083890*Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease
Arthromics 1083891*Topical application of muscarinic analgesic drugs such as neurostigmine
El Khoury, George F 1083892*Multivalent agonists, partial agonists, inverse agonists and antagonists of the D 1? receptors
Advanced Medicine 1083893*Multibinding inhibitors of HMG-CoA reductase
Advanced Medicine 1083894*Use of sclareol-like or scareolide-like compounds for the treatment of microbial infections
RJ Reynolds Tobacco Co 1083895*Use of neomycin for treating angiogenesis-related diseases
The Endowment for Research in Human Biology 1083896*HIV integrase inhibitors
Merck 1083897*Novel use of HIV protease inhibiting compounds
Institut National de la Sante et de la Recherche Medicale 1083898*Method of enhancing lysosomal g(A)-galactosidase A
Fan, Jian-Qiang 1083899*Topical administration of oxazolidinones for transdermal delivery
Pharmacia & Upjohn 1083900*Efavirenz compressed tablet formulation
Merck 1083901*Novel galenic formulations of meloxicam for oral administration
Boehringer Ingelheim Pharma 1083902*Bridged indenopyrrolocarbazoles
Cephalon 1083903*Pharmaceutical compsns and uses for androst-5-ene-3 beta, 17 beta-diol
Endrorecherche 1083904*Selective estrogen receptor modulator in combination with dehydroepiandrosterone (DHEA) or analogues
Endorecherche 1083905*Aminosugar, glycosaminoglycan, and S-adenosylemethionine compsn for the treatment and repair of connective tissue
Nutramax Laboratories 1083906*Use of ozone for the preparation of medicaments for the treatment of dental caries
Glencaste Enterprises 1083908*Use of adeno-associated viruses for decreasing the radiotherapy-induced or chemotherapy-induced resistance in cancer patients
Deutches Krebsforshungszentrum Stiftung des oeffentlichen Rechts 1083911*Antithromibitic agents
Rowett Research Services 1083912*Monoamine oxidase (MAO) inhibitors and uses thereof
Regent Court Technologies 1083913*Treatment of arthritis and other similar conditions
Hull, Peter Hugh 1083914*Compsns and methods for enhancing protein anabolism and detoxification
Vickery, Brice 1083915*Il-6/SIL-6R complex for promotion of liver functions
Hadasit Medical Research Services & Development Company 1083916*Novel analgesic agents
Advanced Medicine 1083917*Novel therapeutic agents that modulate 5-HT receptors
Advanced Medicine 1083918*Novel antiviral agents
Advanced Medicine 1083919*Novel antibacterial compounds
Advanced Medicine 1083920*Novel leukotriene receptor antagonists and their uses
Advanced Medicine 1083921*Compsn and method for treatment of Pseudomonas
Governors of the University of Alberta 1083922*ACRP30R1: a homolog of ACRP30 (30 KD adipocyte complement-related protein)
SmithKline Beecham 1083923*Glucagon-like peptide-1 improves beta-cell response to glucose in subjects with impaired glucose tolerance
Bionebraska 1083924*Acrosomal sperm protein and uses thereof
Immunocon 1083925*Vaccine
SmithKline Beecham Biologicals; The Ohio State University Research Foundation 1083926*Method of inhibiting angiogenesis and tumour growth and preventing tumour metastases
The Mount Sinai School of Medicine, of the City University of New York 1083928*The use of anabolic agents, anticatabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
Nutramax Laboratories 1083929*Insulin-supplemented infant formula
Technion Research & Development 1083930*Stabilisation of compsns containing ACE inhibitors using magnesium oxide
Warner-Lambert 1083931*Homogene pharmaceutical compsns comprising abacavir, lamivudine and zidovudine
Glaxo Group 1083932*Device for the controlled release of active agents in the gastrointestinal tract with a prolonged pylorus passage
LTS Lohmann Therapie-Systeme 1083933*Gene therapy method
Glaxo Group 1083934*Diagnostic method and diagnostic means used in carrying out said method
Porthoff, Klaus 1083936*Radioionated phenols for brachytherapy
Dow Chemical 1083937*Patient-specific dosimetry
Coulter Pharmaceutical; The University of Michigan 1083938*
